{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:45Z","timestamp":1753891965682,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Type 1 diabetes mellitus (T1DM) is characterized by pancreatic beta cell destruction by autoantibodies and other factors, resulting in insulin secretion deficiency. Therefore, beta cell regeneration would be necessary to cure the disease. Nevertheless, the impact of type 1 diabetes on the stemness and transplantation efficiency of stem cells has not been previously described. In this study, we used next-generation sequencing to identify genes differentially expressed in T1DM adipose-derived stem cells (T1DM ADSCs) that originate from patients with type 1 diabetes. Furthermore, we evaluated their effects on transplantation efficiency following xenotransplantation into immunodeficient mice. In the T1DM ADSCs transplant group, the volume and weight of the graft were significantly reduced and the transplant efficiency was reduced. Next-generation sequencing and quantitative PCR results showed that T1DM ADSCs had significantly increased expression of <jats:italic>AMFR<\/jats:italic> and <jats:italic>DCTN2<\/jats:italic>. <jats:italic>AMFR<\/jats:italic> and <jats:italic>DCTN2<\/jats:italic> gene knockdown in T1DM ADSC significantly restored cell proliferation and stem cell marker expression. Therefore, transplantation of T1DM ADSCs, in which <jats:italic>AMFR<\/jats:italic> and <jats:italic>DCTN2<\/jats:italic> were knocked down, into immunodeficient mice improved transplant efficiency. This study revealed that <jats:italic>AMFR<\/jats:italic> and <jats:italic>DCTN2<\/jats:italic> can reduce transplantation efficiency of T1DM ADSCs. Focusing on <jats:italic>AMFR<\/jats:italic> and <jats:italic>DCTN2<\/jats:italic> is expected to increase the efficiency of stem cell transplantation therapy for diabetic patients.<\/jats:p>","DOI":"10.3389\/fphar.2022.1005293","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:58:53Z","timestamp":1664863133000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["AMFR and DCTN2 genes cause transplantation resistance of adipose-derived mesenchymal stem cells in type 1 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Michiko","family":"Horiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Tsurudome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/cbin.11548","article-title":"Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice","volume":"45","author":"Bao","year":"2021","journal-title":"Cell Biol. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.abh1657","article-title":"Strategies for durable \u03b2 cell replacement in type 1 diabetes","volume":"373","author":"Brusko","year":"2021","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0079-6123(08)64379-4","article-title":"Vasopressin and oxytocin: Distribution and putative functions in the brain","volume":"60","author":"Buijs","year":"1983","journal-title":"Prog. Brain Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: A pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13287-020-01793-6","article-title":"Current progress in stem cell therapy for type 1 diabetes mellitus","volume":"11","author":"Chen","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5966\/sctm.2012-0116","article-title":"Stem cell therapy to cure type 1 diabetes: From hype to hope","volume":"2","author":"Chhabra","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2337\/dc17-1779","article-title":"Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia","volume":"41","author":"Foster","year":"2018","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: Controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1038\/s41596-021-00560-y","article-title":"Generation of insulin-producing pancreatic \u03b2 cells from multiple human stem cell lines","volume":"16","author":"Hogrebe","year":"2021","journal-title":"Nat. Protoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1111\/jcmm.16484","article-title":"Characterizing the degeneration of nuclear membrane and mitochondria of adipose-derived mesenchymal stem cells from patients with type II diabetes","volume":"25","author":"Horiguchi","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10906","DOI":"10.3390\/ijms222010906","article-title":"Exosome degeneration in mesenchymal stem cells derived from patients with type 1 diabetes mellitus","volume":"22","author":"Horiguchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.3390\/ijms22126595","article-title":"The transplantation resistance of type II diabetes mellitus adipose-derived stem cells is due to G6PC and IGF1 genes related to the FoxO signaling pathway","volume":"22","author":"Horiguchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1111\/jcmm.16775","article-title":"Identification and characterization of hADSC-derived exosome proteins from different isolation methods","volume":"25","author":"Huang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"Kegg: New perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jdi.12702","article-title":"iPSC technology-based regenerative therapy for diabetes","volume":"9","author":"Kondo","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: From molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jcb.20681","article-title":"Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow","volume":"97","author":"Mareschi","year":"2006","journal-title":"J. Cell Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"100308","DOI":"10.1016\/j.jbo.2020.100308","article-title":"Amplification of autocrine motility factor and its receptor in multiple myeloma and other musculoskeletal tumors","volume":"23","author":"Nakajima","year":"2020","journal-title":"J. Bone Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/neup.12512","article-title":"Dynactin is involved in Lewy body pathology","volume":"38","author":"Shen","year":"2018","journal-title":"Neuropathology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.cell.2011.05.033","article-title":"Strategies for homeostatic stem cell self-renewal in adult tissues","volume":"145","author":"Simons","year":"2011","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1464-5491.2010.03029.x","article-title":"Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in type 1 diabetes: A systematic review","volume":"27","author":"Speight","year":"2010","journal-title":"Diabet. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.1074\/jbc.M207525200","article-title":"The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel","volume":"277","author":"van Balkom","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1005293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:58:56Z","timestamp":1664863136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1005293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":25,"alternative-id":["10.3389\/fphar.2022.1005293"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1005293","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"article-number":"1005293"}}